Bg pattern

ELIXIFILIN 5.33 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ELIXIFILIN 5.33 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Elixifilin 5.33 mg/ml oral solution

Anhydrous theophylline

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What Elixifilin is and what it is used for
  2. What you need to know before you take Elixifilin
  3. How to take Elixifilin
  4. Possible side effects
  5. Storage of Elixifilin
  6. Contents of the pack and other information

1. What Elixifilin is and what it is used for

This medication belongs to a group of medications called bronchodilators, which means it dilates the bronchi and facilitates breathing.

It is indicated for the prevention and treatment of asthma or bronchial spasm associated with lung diseases such as chronic bronchitis or emphysema.

Theophylline should not be the first medication chosen to treat asthma in children.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start taking Elixifilin

Do not takeElixifilin

  • If you are allergic to theophylline or to any other medication in the same group or to any of the other components of this medication (listed in section 6).
  • If you have acute tachyarrhythmia (rapid heart rate).
  • If you have recently had a myocardial infarction.
  • In children under 6 months of age.

Warnings and precautions

Consult your doctor before starting to take Elixifilin.

If you have any of the following diseases, you should inform your doctor as you may need a dose adjustment:

  • If you have heart disease: unstable angina, tachyarrhythmia (rapid heart rate), hypertrophic obstructive cardiomyopathy (abnormally thick heart muscle), heart failure (poor heart function).
  • If you have very high blood pressure.
  • If you have glaucoma (eye disease characterized by increased pressure inside the eyeball).
  • If you have hyperthyroidism (excess thyroid function).
  • If you have epilepsy (seizures).
  • If you have severe hypoxemia or cor pulmonale (lung problems).
  • If you have gastric or duodenal ulcers.
  • If you have liver failure (your liver does not function properly).

Special caution should be exercised when adjusting the dose for patients who meet the following conditions:

  • If you drink alcohol, smoke, or are an ex-smoker, please inform your doctor.
  • If you are an obese patient.
  • If you are over 65 years old, or if you are going to administer it to a child, keep in mind that your doctor should make a dose adjustment before prescribing this medication.
  • If you are taking other medications, please inform your doctor.
  • If you have a fever, it may be necessary to decrease the dose of theophylline.
  • If you visit another doctor or dentist, please inform them that you are taking this product.

Children and adolescents

Elixifilin is not recommended for use in children between 1 year and 6 months of age. Children under 6 months should not take this medication.

The alcohol content of this medication should be taken into account before it is used in children and adolescents.

Other medications and Elixifilin

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Theophylline may decrease or increase the effect of other medications, and in turn, the effect of theophylline may be decreased or increased by other medications if taken together. For this reason, it is necessary to inform your doctor if you are taking:

  • barbiturates (used to produce sedation, relaxation), such as phenobarbital, pentobarbital,
  • medications for epilepsy (carbamazepine, phenytoin, and fosphenytoin),
  • antibiotics (rifampicin and rifapentine),
  • medications for high blood pressure (sulfinpyrazone),
  • products containing hypericum (St. John's Wort).

The levels of theophylline may increase (with a high risk of overdose and adverse reactions) when taking Elixifilin simultaneously with:

  • oral contraceptives,
  • certain antibiotics (erythromycin, troleandomycin, clarithromycin, josamycin, and spiramycin),

quinolones (gyrase inhibitors, especially ciprofloxacin, enoxacin, and pefloxacin), imipenem (especially central nervous system adverse effects such as seizures),

  • isoniazid (treatment of tuberculosis),
  • tiabendazole (treatment of fungi),
  • calcium channel blockers (for heart disease), such as verapamil and diltiazem,
  • propranolol (treatment of hypertension or high blood pressure),
  • mexiletine (treatment of hypertension or high blood pressure),
  • propafenone (treatment of heart problems),
  • ticlopidine (prevention of blood coagulation),
  • cimetidine, ranitidine (prevention of acid production in the stomach)
  • allopurinol, febuxostat (treatment of gout)
  • fluvoxamine (treatment of mental illnesses),
  • interferon alfa and peginterferon alfa-2 (treatment of immunological disorders),
  • zafirlukast (treatment of asthma),
  • influenza vaccines,
  • zileuton (treatment of asthma).
  • other products containing theophylline or other xanthines (such as caffeine and similar substances).

If you are taking any of the medications mentioned above, your doctor may prescribe another medication or adjust the dose of Elixifilin or another medication.

Taking Elixifilin with food, drinks, and alcohol

It should be avoided to ingest, in large quantities, beverages with caffeine, such as: tea, coffee, cocoa, cola drinks, or large amounts of chocolate. These products can increase the adverse reactions of this medication.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.

Pregnancy

The use of theophylline is not recommended during pregnancy.

Breastfeeding

The use of theophylline is not recommended during breastfeeding.

Consult your doctor or pharmacist before using any medication.

The alcohol content of this medication should be taken into account in the case of pregnant or breastfeeding women.

Interference with diagnostic tests

If you are going to undergo any diagnostic tests (including blood tests, urine tests, skin tests using allergens), inform your doctor that you are taking this medication, as it may alter the results.

Driving and using machines

This medication may alter your reaction speed, so you should be careful when driving and/or using machines, especially at the start of treatment, when changing the dose, or when administering it together with other medications.

Due to its ethanol content, it is recommended not to drive or operate hazardous machinery.

Elixifilin contains sucrose, ethanol, and amaranth (E123)

This medication contains sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

It may cause cavities.

This medication contains 10.66% ethanol (alcohol), which corresponds to an amount of 2,575.2 mg of ethanol per 30 ml dose, equivalent to 64 ml of beer or 27 ml of wine.

This medication is harmful to people with alcoholism.

The alcohol content should be taken into account in the case of pregnant or breastfeeding women, children, and high-risk groups, such as patients with liver disease or epilepsy.

This medication may cause allergic reactions because it contains amaranth (E123).

It can cause asthma, especially in patients allergic to acetylsalicylic acid.

3. How to take Elixifilin

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is:

Adults and adolescents over 16 years old

A medium recommended dosage for an adult is 160 mg of theophylline equivalent to 30 ml (2 dose measuring caps) of oral solution three times a day, sufficiently spaced: in the morning, at noon, and at bedtime.

If theophylline blood levels are not controlled, you should never take more than 20 mg/kg/day of theophylline.

Smoking patients may require higher doses of the preparation and/or shorter intervals. The dose for ex-smoking patients should be carefully selected due to a possible change in the theophylline dose.

In the case of patients with liver failure, congestive heart failure, over 65 years old, and obese patients, lower doses should be used.

Adults and adolescents Theophylline

over 16 years old mg/Kg/day

Smokers 15

Non-smokers 11

  • cardiac, cor pulmonale,

acute pulmonary edema 7

  • hepatic 5
  • cardiac and hepatic 2

over 65 years old 9.5

Pediatric population

Children and adolescents between 1 and 16 years old

The metabolism of theophylline changes during growth, becoming similar to that of an adult around 16 years old. The maximum recommended doses are:

Children and adolescents Theophylline

between 1 and 16 years old mg/Kg/day

1-9 years 21

9-12 years 18

12-16 years 13

Children between 1 year and 6 months old

The use of this medication is not recommended.

Children under 6 months old

Elixifilin should not be used in children under 6 months old.

How to take Elixifilin:

This medication is taken orally.

If you experience digestive discomfort with this medication, you can take it with food.

If you take moreElixifilinthan you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

Intoxication can manifest with agitation, logorrhea (excessive and disordered use of words when speaking), mental confusion, vomiting, fever, rapid heart rate, and very low blood pressure. In adults, there may also be seizures and cardiac arrest.

If you forget to takeElixifilin

If you forget to take a dose of this medication, take the next dose as prescribed. Do not take a double dose to make up for forgotten doses.

It is important that you continue taking Elixifilin until your doctor tells you otherwise.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone gets them.

During the period of use of theophylline, the following side effects have been observed, whose frequency could not be established from the available data. These are more frequently associated with theophylline plasma levels above 20 micrograms/ml.

Nervous system disorders

Irritability, nervousness, headache, insomnia, hyperexcitability, muscle contractions, seizures, behavioral changes.

Cardiac disorders:

Palpitations, sinus or ventricular tachycardia, extrasystoles or ventricular arrhythmia.

Vascular disorders:

Peripheral vasodilation and hypotension.

Gastrointestinal disorders:

Nausea, vomiting, diarrhea, and pain in the upper abdomen (epigastrium).

Skin and subcutaneous tissue disorders:

Skin rashes.

Complementary tests:

Reduction of prothrombin time and increase of serum GOT.

When overdose is suspected, a control of theophylline plasma concentration should be requested. If this is not possible, the dose should be reduced or administration should be suspended, depending on the severity of the symptoms.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines (website: www.notificaRAM.es). By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Elixifilin

Keep this medication out of the sight and reach of children.

Do not store above 25°C.

Keep in the outer packaging to protect from light.

Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Place the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.

6. Contents of the pack and other information

Composition ofElixifilin 5.33 mg/ml oral solution

  • The active ingredient is theophylline. Each milliliter contains 5.33 mg of theophylline.
  • The other components (excipients) are: citric acid monohydrate (E330), ethanol, sucrose, cherry flavor, ethyl vanillin, glycerol (E422), amaranth (E123), sodium saccharin (E954), silicone antifoam, quinoline yellow (E104), purified water.

Appearance of the product and packaging contents

Brown glass bottle containing 250 ml of oral solution, including a 15 ml dose measuring cap with measures of 2.5, 3.75, 5, 7.5, 10, and 15 ml.

Marketing authorization holder and manufacturer:

Marketing authorization holder

Tora Laboratories, S.L.U.

Avenida de Oporto, 60

28019 Madrid, Spain

Manufacturer

Farmasierra Manufacturing, S.L.

Carretera de Irún Km 26,200

San Sebastián de los Reyes

28709 Madrid

Spain

Date of the last revision of this leaflet:October 2021

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ELIXIFILIN 5.33 mg/ml ORAL SOLUTION

Discuss questions about ELIXIFILIN 5.33 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (766)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for ELIXIFILIN 5.33 mg/ml ORAL SOLUTION?
ELIXIFILIN 5.33 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ELIXIFILIN 5.33 mg/ml ORAL SOLUTION?
The active ingredient in ELIXIFILIN 5.33 mg/ml ORAL SOLUTION is theophylline. This information helps identify medicines with the same composition but different brand names.
How much does ELIXIFILIN 5.33 mg/ml ORAL SOLUTION cost in pharmacies?
The average pharmacy price for ELIXIFILIN 5.33 mg/ml ORAL SOLUTION is around 2.5 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ELIXIFILIN 5.33 mg/ml ORAL SOLUTION?
ELIXIFILIN 5.33 mg/ml ORAL SOLUTION is manufactured by Tora Laboratories S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ELIXIFILIN 5.33 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ELIXIFILIN 5.33 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ELIXIFILIN 5.33 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (theophylline) include TEROMOL RETARD 300 mg PROLONGED-RELEASE TABLETS, THEO-DUR 100 mg PROLONGED-RELEASE TABLETS, THEO-DUR 200 mg PROLONGED-RELEASE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media